In contrast, blocking FXR activation increases Src (Tyr416) phosphorylation, which in turn activates EGFR and post-receptor ERK1/2 signaling, thereby resulting in increased cell proliferation and tumor growth (Fig. 8F, right panel). This evidence concerns the gene SRC and neoplasm.